INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL

被引：0

作者：

Kebir, Sied ^{[1
,2
]}

Lazaridis, Lazaros ^{[1
,2
]}

Schmidt, Teresa ^{[1
,2
]}

Oster, Christoph ^{[1
,2
]}

Feldheim, Jonas ^{[3
,4
]}

Pierscianek, Daniela ^{[5
]}

Proescholdt, Martin ^{[6
]}

Hau, Peter ^{[7
,8
]}

Grosu, Anca-Ligia ^{[9
]}

Krex, Dietmar ^{[10
]}

Sure, Ulrich ^{[11
]}

Scheffler, Bjoern ^{[12
]}

Kleinschnitz, Christoph ^{[1
,2
]}

Poettgen, Christoph ^{[13
]}

Stuschke, Martin ^{[14
]}

Glas, Martin ^{[1
,2
]}

机构：

[1] Univ Duisburg Essen, Univ Med Essen, Dept Neurol, Essen, Germany

[2] Univ Duisburg Essen, Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[3] Univ Med Essen, Dept Neurol, Essen, Germany

[4] Univ Med Essen, Div Clin Neurooncol, Ctr Translat Neuro & Behav Sci C TNBS, Essen, Germany

[5] Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[6] Univ Regensburg, Dept Neurosurg, Med Ctr, Regensburg, Germany

[7] Univ Hosp Regensburg, Dept Neurol, Regensburg, CA USA

[8] Univ Hosp Regensburg, Wilhelm Sander Neurooncol Unit, Regensburg, CA USA

[9] Med Ctr Univ Freiburg, Dept Radiat Oncol, Freiburg, Germany

[10] Tech Univ Dresden, Univ Hosp Carl Gustav Carus, Dept Neurosurg, Dresden, Germany

[11] Univ Duisburg Essen, Univ Med Essen, Dept Neurosurg & Spine Surg, Essen, Germany

[12] German Canc Res Ctr, Heidelberg, Germany

[13] Univ Med Essen, Dept Radiotherapy, Essen, Germany

[14] Univ Duisburg Essen, Univ Med Essen, Dept Radiotherapy, Essen, Germany

来源：

NEURO-ONCOLOGY | 2023年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

CTNI-65

引用

页数：2

共 50 条

[1] INVESTIGATING SAFETY AND EFFICACY OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA - FIRST RESULTS OF THE PRICOTTF PHASE I/II TRIAL
Kebir, Sied
Lazaridis, Lazaros
Schmidt, Teresa
Oster, Christoph
Feldheim, Jonas
Pierscianek, Daniela
Proescholdt, Martin
Hau, Peter
Grosu, Anca-Ligia
Krex, Dietmar
Sure, Ulrich
Scheffler, Bjoern
Kleinschnitz, Christoph
Poetgen, Christoph
Stuschke, Martin
Glas, Martin
NEURO-ONCOLOGY, 2022, 24 : 77 - 77
[2] Investigating safety and efficacy of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma-the PriCoTTF phase I/II trial
Kebir, S.
Lazaridis, L.
Schmidt, T.
Oster, C.
Feldheim, J.
Glas, M.
Pierscianek, D.
Proescholdt, M.
Hau, P.
Grosu, A.
Krex, D.
Scheffler, B.
Kleinschnitz, C.
Pottgen, C.
Stuschke, M.
NEURO-ONCOLOGY, 2022, 24
[3] Safety and efficacy of TTFields therapy prior and concomitant to radiotherapy in newly diagnosed glioblastoma - the PriCoTTF phase I/II trial
Kebir, Sied
Lazaridis, Lazaros
Schmidt, Teresa
Oster, Christoph
Feldheim, Jonas
Proescholdt, Martin
Hau, Peter
Grosu, Anca Ligia
Krex, Dietmar
Pierscianek, Daniela
Sure, Ulrich
Scheffler, Bjoern
Kleinschnitz, Christoph
Stuschke, Martin
Glas, Martin
STRAHLENTHERAPIE UND ONKOLOGIE, 2023, 199 : S32 - S32
[4] PriCoTTF Trial: A phase I/II trial of TTFields prior and concomitant to radiotherapy in newly diagnosed glioblastoma
Kebir, S.
Lazaridis, L.
Schmidt, T.
Oster, C.
Pierscianek, D.
Guberina, N.
Kleinschnitz, C.
Proescholdt, M.
Hau, P.
Grosu, A. -L
Sure, U.
Scheffler, B.
Stuschke, M.
Glas, M.
STRAHLENTHERAPIE UND ONKOLOGIE, 2020, 196 (SUPPL 1) : S74 - S74
[5] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, Sied
Lazaridis, Lazaros
Schmidt, Teresa
Oster, Christoph
Pierscianek, Daniela
Guberina, Nika
Kleinschnitz, Christoph
Proescholdt, Martin
Hau, Peter
Grosu, Anca-Ligia
Sure, Ulrich
Scheffler, Bjoern
Stuschke, Martin
Glas, Martin
NEURO-ONCOLOGY, 2020, 22 : 61 - 61
[6] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, Sied
Pierscianek, Daniela
Proescholdt, Martin
Hau, Peter
Grosu, Anca-Ligia
Krex, Dietmar
Sure, Ulrich
Scheffler, Bjoern
Stuschke, Martin
Glas, Martin
NEURO-ONCOLOGY, 2021, 23 : 68 - 68
[7] PRICOTTF TRIAL: A PHASE I/II TRIAL OF TTFIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Kebir, S.
Pierscianek, D.
Proescholdt, M.
Hau, P.
Grosu, A.
Krex, D.
Sure, U.
Scheffler, B.
Stuschke, M.
Glas, M.
NEURO-ONCOLOGY, 2021, 23 : 50 - 50
[8] Safety and efficacy of tumor treating fields (TTFields) prior and concomitant to radiotherapy in patients with newly diagnosed glioblastoma: Results from PriCoTTF
Kebir, Seid
Lazaridis, Lazaros
Schmidt, Teresa
Oster, Christoph
Proescholdt, Martin
Hau, Peter
Grosu, Anca L.
Krex, Dietmar
Sure, Ulrich
Scheffler, Bjoern
Kleinschnitz, Christoph
Ttgen, Christoph Po Spacing Diaeresis
Stuschke, Martin
Glas, Martin
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
[9] PRICOTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Glas, M.
Scheffler, B.
Lazaridis, L.
Herrlinger, U.
Pierscianek, D.
Sure, U.
Proescholdt, M.
Hau, P.
Hense, J.
Kleinschnitz, C.
Grosu, A.
Stuschke, M.
Kebir, S.
NEURO-ONCOLOGY, 2018, 20 : 243 - 243
[10] PriCoTTF: A PHASE I/II TRIAL OF TUMOR TREATING FIELDS PRIOR AND CONCOMITANT TO RADIOTHERAPY IN NEWLY DIAGNOSED GLIOBLASTOMA
Glas, Martin
Scheffler, Bjoern
Lazaridis, Lazaros
Herrlinger, Ulrich
Pierscianek, Daniela
Sure, Ulrich
Proescholdt, Martin
Hau, Peter
Hense, Joerg
Kleinschnitz, Christoph
Grosu, Anca-Ligia
Stuschke, Martin
Kebir, Sied
NEURO-ONCOLOGY, 2018, 20 : 22 - 22

← 1 2 3 4 5 →